DBS denied for failing step therapy by Blue Cross Blue Shield?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Blue Cross Blue Shield typically requires
Blue Cross Blue Shield's specific coverage criteria for dbs are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Blue Cross Blue Shield angle on DBS
## Why BCBS Issues Step-Therapy Denials for Deep Brain Stimulation (DBS)
Step-therapy for deep brain stimulation means BCBS requires documentation that the patient has first tried — and had inadequate results from — a sequence of less invasive or less costly treatments before DBS will be approved. For movement disorders such as Parkinson's disease or essential tremor, this typically means demonstrating an adequate trial of optimized pharmacological therapy. For conditions such as OCD, it may involve documented trials of behavioral therapy and medication. The denial occurs most often when the prior treatment history is not presented in a format that clearly maps to each step BCBS requires, even when the patient has genuinely completed those steps over years of care.
## Why This Denial Is Appealable
Step-therapy denials are among the most consistently overturned denials on appeal, because in the DBS context the required prior steps are almost always already completed by the time DBS is considered. Neurologists and movement-disorder specialists do not refer patients for DBS evaluation until medical management has been thoroughly optimized. The appeal task is documentary: showing that the steps have been completed, not convincing the insurer that steps should be skipped. Many states also have step-therapy override laws that require an insurer to grant an exception when prior steps have been tried and failed.
## Federal Appeal Framework
- Internal appeal: File within the timeframe on your denial notice. BCBS must respond within 30 days for pre-service non-urgent appeals or 72 hours for expedited/urgent cases.
- State step-therapy override: If your state has enacted step-therapy protection legislation, file a simultaneous override request. Your prescriber must certify that required prior steps were tried, failed, or are contraindicated.
- External review (ACA §2719 / ERISA §503): After final internal denial, request independent external review within approximately four months. External reviewers frequently overturn step-therapy denials when the documented prior-treatment history clearly satisfies the required steps.
## Documentation to Gather
1. Complete medication history — a comprehensive list of every medication tried for the condition, with prescribing dates, dosing history, duration of use, and documented outcome (inadequate efficacy, intolerance, adverse effect, or contraindication). 2. Specialist notes — movement-disorder neurologist or equivalent specialist notes documenting the progressive optimization of medical management and the decision to evaluate for DBS. 3. DBS candidacy evaluation — neurosurgery and/or movement-disorder evaluation confirming DBS candidacy and the clinical reasoning. 4. Functional severity documentation — objective measures of symptom severity and functional impact despite optimized medical therapy, showing that less invasive options are no longer adequate. 5. Prescriber step-therapy letter — a letter from your neurologist and/or neurosurgeon that explicitly maps each BCBS-required step to the documented treatment history, confirming completion of each step and explaining why further medical management is not appropriate.
## Criteria-Mapping Structure
Obtain BCBS's step-therapy or prior-authorization criteria for DBS. Build a table that maps every required step to documented history:
| Required Step-Therapy Element | Documentation | |---|---| | Trial of required medication class(es) | [drug names, dates, duration, outcome] | | Dose optimization documented | [prescriber notes on optimization attempts] | | Inadequate response confirmed | [clinical assessment, symptom scores] | | Specialist referral and evaluation | [movement-disorder evaluation note, date] | | DBS candidacy confirmed | [neurosurgery evaluation, date] |
The step-therapy appeal package for DBS is strongest when organized as a narrative timeline — showing the full arc of medical management from diagnosis through the decision to pursue DBS — rather than as a collection of unconnected records.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →Related appeal guides
- Blue Cross Blue Shield denied for failing step therapy of 17ohp Compounded
- Blue Cross Blue Shield denied for failing step therapy of AAT Augmentation
- Blue Cross Blue Shield denied for failing step therapy of Amphetamine Stimulant Prodrug
- Blue Cross Blue Shield denied for failing step therapy of Anti Cd 20 Ocrevus